Application Sponsors
ANDA 216462 | GLENMARK PHARMS LTD | |
Marketing Status
Application Products
001 | TABLET;ORAL | 500MG | 0 | SODIUM PHENYLBUTYRATE | SODIUM PHENYLBUTYRATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-11-01 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
GLENMARK PHARMS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 216462
[companyName] => GLENMARK PHARMS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"SODIUM PHENYLBUTYRATE","activeIngredients":"SODIUM PHENYLBUTYRATE","strength":"500MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"11\/01\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-11-01
)
)